Share Article

UsToo and Dr. Daniel Fried Present Live Webcast and Q and A on Prostate Cancer Radiation Therapy

Request More Information
Summary of Article

The event featured a presentation from renowned radiation oncologist Daniel B. Fried, MD, MPH, PhD, who practices at the Gibbs Cancer Center and Research Institute in Greenville, S.C discussing radiation therapy as an option for prostate cancer treatment.

Watch Now

In the fall of 2017, Us TOO International held a live webcast on radiation therapy for their prostate cancer support group meeting. The event, held in Greenville, SC, was sponsored by Augmenix, INC. The topic for the meeting was “Hydrogel Rectal Spacer in Prostate Radiotherapy”, specifically highlighting SpaceOAR hydrogel.

Dr. Daniel Fried, a radiation oncologist from Gibbs Cancer Center and Research Institute, was the speaker at the meeting, presenting on his experience with SpaceOAR hydrogel as well as answering questions from the audience about prostate cancer treatment and diagnosis. Gibbs Cancer Center and Research Institute is the first SpaceOAR National Education Resource Center.

More than 160,000 men will be diagnosed with prostate cancer in 2017 and we’re on a mission to help educate those affected so they’re empowered to make informed decisions on all aspects of the disease,”

-Chuck Strand, CEO, Us TOO International.

Us TOO’s mission is to provide hope and improvement to the lives of the prostate cancer patients as well as their families and friends through support, education, and advocacy/awareness. Representatives of Us TOO whom attended the webinar included CEO Chuck Strand, Terri Likowski, Program Director/Support Group Services, and Johnny Payne, the Leader of the Us TOO Harvey Floyd Support Group.

Dr. Daniel Fried discusses radiation therapy for Prostate Cancer at an UsToo Support group meeting held in Greenville, SC
Dr. Fried addresses questions from the audience
The audience had some great questions for Dr. Fried.
Johnny Payne, Leader of the Us TOO support group in Greenville, SC

To find a local Us TOO International support group, visit

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

Caution: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device. Information for use only in countries with applicable health authority registrations. This material not intended for use in France. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.

Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary. BSC strongly recommends that you consult with your physician on all matters pertaining to your health or to address any questions.

As with any medical treatment, there are some risks involved with the use of SpaceOAR Hydrogel. Potential complications associated with SpaceOAR Hydrogel include, but are not limited to: pain associated with SpaceOAR Hydrogel injection; pain or discomfort associated with SpaceOAR Hydrogel; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR Hydrogel into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR Hydrogel intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.
© 2019 Boston Scientific Corporation or its affiliates. All rights reserved. URO-709508-AA NOV 2019